INTERNATIONAL PATENT: ARETEIA THERAPEUTICS, INC. FILES APPLICATION FOR "USE OF DEXPRAMIPEXOLE FOR THE TREATMENT OF EOSINOPHILIC COPD"

GENEVA, Nov. 26 -- ARETEIA THERAPEUTICS, INC. (101 Glen Lennox Drive, Suite 300Chapel Hill, North Carolina 27517) filed a patent application (PCT/US2025/029881) for "USE OF DEXPRAMIPEXOLE FOR THE TREATMENT OF EOSINOPHILIC COPD" on May 16, 2025. With publication no. WO/2025/240942, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRADFORD, Eric (124 New Castle DriveChapel Hill, North Carolina 27517), PRUSSIN, Calman (11608 Danville DriveRockville, Maryland 20852), STEINFELD, Jonathan (538 Manayunk RoadMerion Station, Pennsy...